Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: A systematic review and meta-analysis

Antonio Facciorusso, Nicola Tartaglia, Rosanna Villani, Gaetano Serviddio, Daryl Ramai, Babu P. Mohan, Saurabh Chandan, Mohamed A.Abd El Aziz, Jessica Evangelista, Christian Cotsoglou, Antonio Ambrosi

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: A systematic review and meta-analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds